Program overview
Context
Indication: Colorectal Cancer Metastatic
Mechanism: Unknown
Modality: Unknown
Sponsor: NSABP Foundation
Registry Stop Signal
durvalumab
durvalumab is flagged as registry stop signal because public records show a registry stop signal, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 5/5
Timeline: 1/5
Recruitment burden: 2/5
Results availability: 0/5
Program risk: 4/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT03007407 | https://clinicaltrials.gov/study/NCT04245514 | https://clinicaltrials.gov/study/NCT02431559 | https://clinicaltrials.gov/study/NCT02938793
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT03007407 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | rare_population_signal | strict_eligibility_signal |
| NCT04245514 | Low Signal (ACTIVE_NOT_RECRUITING) | long_recruitment_duration_signal | Low Signal | rare_population_signal | strict_eligibility_signal |
| NCT02431559 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | strict_eligibility_signal |
| NCT02938793 | Registry Stop Signal (TERMINATED) | None | Low Signal | rare_population_signal | strict_eligibility_signal |